4 results  1 of 1 

1 Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis
Kyoung-Woon Kim, Hae-Rim Kim, Bo-Mi Kim, Ji-Yeon Won, Kyung-Ann Lee, Sang-Heon Lee
Immune Netw.2019;19(4):e27.  Published online 2019 August 6     DOI: http://dx.doi.org/10.4110/in.2019.19.e27
      
2 Japanese-B Viral Encephalitis with a Biphasic Illness Pattern and Recovery after Intravenous Immunoglobulin Therapy
Byung-Chan Lee, Ji Ye Jeon, Hye-Jin Moon, Jeong Geun Lim, Yong Won Cho
Korean J Clin Neurophysiol.2014;16(1):35-38.   Published online 2014 January 18     DOI: http://dx.doi.org/10.14253/kjcn.2014.16.1.35
   
3 A Case of Intravenous Immunoglobulin-Resistant Kawasaki Disease Treated with Methotrexate
Mi Seon Lee, Seon Young An, Gwang Cheon Jang, Dong Soo Kim
Yonsei Med J.2002;43(4):527-532.   Published online 2009 April 1     DOI: http://dx.doi.org/10.3349/ymj.2002.43.4.527
      
4 Decreased CD5+ B cells during the acute phase of Kawasaki disease
Hee Soo Kim, Geun Woong Noh, Dong Soo Kim, Ki Young Lee, Hee Sun Lee, Hong Kyu Lee, Soon Il Lee
Yonsei Med J.1996;37(1):52-58.   Published online 2002 February 20     DOI: http://dx.doi.org/10.3349/ymj.1996.37.1.52
      

 1 of 1